Release Date: 28/10/21 08:11 Summary: Quarterly Activities & Cashflow Reports Price Sensitive: Yes Download Document 858.31KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%